awmsg logo



tiotropium (Spiriva® Respimat®)


Reference No. 1882


Appraisal information

tiotropium (Spiriva® Respimat®) 2.5 microgram inhalation solution


Company: Boehringer Ingelheim Ltd
BNF category: Respiratory system
NMG meeting date: 10/10/2018
AWMSG meeting date: 14/11/2018
   
   
Submission Type: Limited Submission
Status: In progress
Advice No: Not available
Ratification by Welsh Government: Not available

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

Indication

As add-on maintenance bronchodilator treatment in patients aged 6 years to <18 years with severe asthma who experienced one or more severe asthma exacerbations in the preceding year
Preliminary Appraisal Recommendation (PAR)
Download
Company Response to the Preliminary Appraisal Recommendation (CR PAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download